Indonesian Deputy Minister of Health Dante Saksono Harbuwono emphasized that the government is fully committed to continuing to combat dengue fever through integrated preventive measures. Seeing the increase in cases that occurred from 2023 to 2024, he said, more effective and innovative preventive measures are needed.
In this regard, Dante said the Indonesian government was implementing six national strategies for handling the pandemic. dengue. First, safe and sustainable vector reinforcement management. Second, improving access and quality of dengue management.
Third, strengthening surveillance dengue comprehensive and responsive KLB management. Fourth, increasing sustainable community involvement.
Fifth, strengthening government commitment, policy-program management, and partnerships. Sixth, developing studies, interventions, innovations, and research as the basis for evidence-based policies and program management.
“But of course, the success of dengue control does not only depend on the government’s commitment, but also requires support from all parties. Cross-sector synergistic collaboration is very important to ensure that dengue prevention and control can run effectively throughout Indonesia,” he said in a media briefing on Indonesian Leadership in Fighting Dengue held by PT Takeda Innovative Medicines in Jakarta, Thursday (19/9).
DBD, which is caused by four serotypes of the virus dengue, is a serious disease that can affect a person more than once, with subsequent infections potentially more severe. The World Health Organization (WHO) noted that as of April 2024, there were more than 7.6 million global cases with more than 3,000 deaths.
Also read: Dengue Fever Confirmed to be a Dangerous Disease
Indonesia itself is one of the countries with the highest dengue fever prevalence rates in Southeast Asia. Data from the Indonesian Ministry of Health states that more than 190,561 cases and 1,141 deaths have been reported up to the 36th week of this year, up from 114,720 cases and 894 deaths in 2023.
The economic burden of dengue fever is also significant. BPJS Kesehatan recorded financing of up to IDR 1.3 trillion in 2023, a sharp increase from IDR 626 billion in the previous year.
On the same occasion, President Director of PT Takeda Innovative Medicines, Andreas Gutknecht, said that all parties need to play an active role in preventing dengue fever to make changes.
“Prevention is the key to fighting dengue fever. There are three steps we can take together, namely educating ourselves and others about dengue fever and its prevention, controlling mosquitoes with 3M Plus, and finally utilizing innovative prevention methods such as dengue vaccines,” he explained. (H-2)
#Government #Implements #National #Strategies #Combat #Dengue #Fever
